Heparin coating, surface modification

In parallel to catheter-based delivery, stent-based approaches, such as passive stent coatings (diamond-like carbon, phosphorylcholine, and silicon carbide coatings) and immobilized drug coatings (heparin-coated stents), were evaluated for their ability to inhibit restenosis. Although animal studies demonstrated some promise, none of these technologies were clinically successful for restenosis prevention. The failure of these surface modification technologies further added to the need for the development of DES based on the principles of sustained CDD,... 

Interest continues in the binding of heparin to polymers in an attempt to produce non-thrombogenic surfaces. This has been the aim in the use of glutaralde-hyde-protein complexes as coatings for latex rubber and polyurethanes. Glutaraldehyde has also been used to bind antibodies to partially hydrolysed polyamide surfaces for enzyme-linked radioassay techniques. One of the few examples of direct polymerization (as opposed to surface modification) in an attempt to produce polymers having improved compatibility involves the use of 2-methacryloyloxyethylphosphoryl choline in the formation of homopolymers and copolymers with methyl methacrylate. An isocyanato-urethane methacrylate has been synthesized from 2-hydroxyethyl methacrylate in connection with dental materials research in which the preparation of poly functional monomers for improvement of interfacial bonding with tooth tissue is a topic of some interest. 

Modification of polyurethanes as a blood contacting material is achieved by coating the polymer surface with heparin as the most suitable biomolecule that avoids thrombogenesis. The immobilization needs a functionalized surface that may offer sites for the heparin bonding. It is observed that helium plasma treatment of polyacrylonitrile and polysulfone followed by exposure to air leads to peroxide species of the order of 10 nmol/cm which are available for decomposition... 

---